Prednisone Increases WBC Count, Not Suppresses It
Prednisone causes leukocytosis (elevated WBC count), not suppression—this is a dose-dependent effect that occurs as early as the first day of treatment and persists throughout therapy, predominantly due to neutrophilia. 1, 2
Mechanism of Corticosteroid-Induced Leukocytosis
Corticosteroids are lymphocyte-depleting agents that paradoxically increase total WBC count by causing neutrophil demargination from blood vessel walls and reducing neutrophil migration to tissues, resulting in a net increase in circulating white blood cells. 1
The leukocytosis pattern is characterized by:
Magnitude and Timing of WBC Elevation
WBC count can increase by 2.4 × 10⁹/L at 48 hours after steroid administration, with peak effects occurring within the first 2 days. 3
Dose-dependent response:
Even small doses of prednisone administered over prolonged periods can induce extreme and persistent leukocytosis, with WBC counts exceeding 20,000/mm³ as early as the first day of treatment. 2
Maximal leukocytosis typically occurs within 2 weeks, after which WBC counts may decrease slightly but remain elevated above baseline throughout therapy. 2
Clinical Implications: Distinguishing Steroid Effect from Infection
The critical challenge is differentiating corticosteroid-induced leukocytosis from infection-related leukocytosis, particularly in immunocompromised patients. 1, 2
Key Diagnostic Features:
Investigate for infection when WBC >14,000/mm³ with left shift (>6% band forms), regardless of steroid dose. 1
Peripheral smear findings help distinguish infection from steroid effect:
Any WBC increase after low-dose steroids, or increases exceeding 4.84 × 10⁹/L after high-dose steroids, suggest alternative causes such as infection. 3
Context-Specific Monitoring
In inflammatory bowel disease patients, glucocorticoids increase WBC count while other immunosuppressive drugs (azathioprine, 6-mercaptopurine) decrease WBC count. 4
Serial WBC monitoring with differential is necessary if infection is suspected in patients on high-dose steroids, rather than relying on a single elevated value. 1
C-reactive protein (CRP) levels decrease with prednisone treatment (mean reduction of 46% by days 3-7), while procalcitonin (PCT) levels remain unaffected and may better reflect true infection status. 5
Important Caveats
Individual patient responses to steroids are highly variable but reproducible in the same patient with the same dose—WBC increases can range from -600 to +8,000/mm³ with no clear correlation to steroid dose. 6
Leukocytosis may be blunted or absent in severely immunocompromised patients, making infection diagnosis more challenging in this population. 1
Maintain heightened vigilance for occult infection even without fever in patients on chronic steroids, as typical inflammatory responses may be masked. 1